Immunophenotyping by Flow Cytometry CD13 Test
Comprehensive Introduction to CD13 Immunophenotyping
Immunophenotyping by Flow Cytometry CD13 represents a cutting-edge diagnostic approach that revolutionizes the detection and characterization of hematological malignancies. This sophisticated laboratory technique utilizes advanced flow cytometry technology to identify and quantify CD13 surface markers on blood cells, providing crucial insights for cancer diagnosis and management. The CD13 antigen, also known as aminopeptidase N, serves as a vital marker expressed on myeloid cells and plays a significant role in cellular differentiation and immune function.
At GGC DNA, we understand the critical importance of accurate cancer diagnosis. Our Immunophenotyping by Flow Cytometry CD13 Test employs state-of-the-art instrumentation and expert analysis to deliver reliable results that guide treatment decisions. This test has become an indispensable tool in modern hematology and oncology practice, enabling healthcare providers to make informed decisions about patient care with confidence.
What the CD13 Test Measures and Detects
The Immunophenotyping by Flow Cytometry CD13 Test specifically measures the presence and distribution of CD13 antigens on the surface of blood cells. This comprehensive analysis provides:
- Identification of CD13 expression patterns on myeloid cells
- Characterization of abnormal cell populations in blood and bone marrow
- Detection of minimal residual disease following treatment
- Differentiation between various types of leukemia
- Assessment of treatment response and disease progression
Flow cytometry technology works by passing single cells through a laser beam while detecting scattered light and fluorescence from labeled antibodies. This allows for precise identification of cell types based on their surface markers, including CD13, which is particularly important for myeloid lineage identification.
Who Should Consider the CD13 Immunophenotyping Test
This advanced diagnostic test is recommended for individuals presenting with specific clinical indications and symptoms that may suggest hematological disorders:
Clinical Indications Include:
- Unexplained cytopenias (low blood cell counts)
- Suspected acute myeloid leukemia (AML)
- Myelodysplastic syndromes evaluation
- Monitoring treatment response in myeloid malignancies
- Evaluation of bone marrow disorders
- Suspected minimal residual disease
Symptoms That May Warrant Testing:
- Persistent fatigue and weakness
- Unexplained bruising or bleeding
- Frequent infections
- Unexplained weight loss
- Bone pain or tenderness
- Enlarged lymph nodes or spleen
Significant Benefits of CD13 Immunophenotyping
Choosing the Immunophenotyping by Flow Cytometry CD13 Test provides numerous advantages for patients and healthcare providers:
- Accurate Diagnosis: Precise identification of CD13 expression helps differentiate between various hematological malignancies
- Treatment Guidance: Results inform targeted therapy selection and treatment planning
- Rapid Results: Same-day reporting when samples are submitted by 9 AM
- Minimal Sample Requirement: Requires only small blood or bone marrow volumes
- Comprehensive Analysis: Provides detailed information about cell populations and their characteristics
- Monitoring Capability: Enables tracking of disease progression and treatment response
Understanding Your CD13 Test Results
Interpreting Immunophenotyping by Flow Cytometry CD13 results requires specialized medical expertise. Here’s general guidance on what your results might indicate:
Normal Results:
- CD13 expression primarily on myeloid cells at expected levels
- No abnormal cell populations detected
- Normal distribution of hematopoietic cells
Abnormal Findings May Include:
- Increased CD13 expression suggesting myeloid proliferation
- Aberrant CD13 patterns indicating malignant transformation
- Presence of abnormal blast populations
- Evidence of minimal residual disease
It’s essential to discuss your specific results with your oncologist or hematologist, who will interpret them in the context of your complete clinical picture, including symptoms, physical examination findings, and other laboratory results.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Immunophenotyping by Flow Cytometry CD13 Test | $88 USD | $126 USD |
Convenient Testing Locations Across the USA
GGC DNA maintains comprehensive testing facilities throughout major metropolitan areas across the United States. Our strategically located branches ensure convenient access to advanced diagnostic services in cities including:
- New York City and surrounding areas
- Los Angeles and Southern California
- Chicago and the Midwest region
- Houston and Texas metropolitan areas
- Miami and South Florida
- San Francisco Bay Area
- Boston and New England
- Washington D.C. and surrounding regions
Take Action for Your Health Today
Don’t delay essential diagnostic testing. The Immunophenotyping by Flow Cytometry CD13 Test provides critical information for managing hematological conditions and guiding appropriate treatment. Our experienced team is ready to assist you with scheduling and answer any questions about the testing process.
Call or WhatsApp us today at +1(267) 388-9828 to book your test or speak with our genetic counseling specialists. Early detection and accurate diagnosis can make a significant difference in treatment outcomes and quality of life.
Our commitment to excellence in diagnostic testing ensures that you receive the highest quality care and most accurate results available. Trust GGC DNA for your immunophenotyping needs and take the first step toward comprehensive health management.
